IGC Pharma Sells Vancouver Assets to Wellness Essentials

IGC Pharma ( (IGC) ) just unveiled an announcement.

IGC Pharma, Inc., through its subsidiary Holi Hemp LLC, completed the sale of certain assets from its Vancouver, Washington facility to Wellness Essentials Northwest LLC on November 13, 2025. The transaction, valued at approximately $2.7 million, involved the transfer of equipment, inventory, and leasehold assets, with the buyer assuming certain employees and lease obligations. The deal includes rights for the buyer to manufacture IGC’s products at preferential pricing until 2030, and a contingent right for IGC to receive a portion of net proceeds if the buyer sells the business within five years. This strategic move is expected to streamline IGC’s operations and enhance its financial position.

The most recent analyst rating on (IGC) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on IGC Pharma stock, see the IGC Stock Forecast page.

Spark’s Take on IGC Stock

According to Spark, TipRanks’ AI Analyst, IGC is a Neutral.

IGC Pharma’s overall stock score reflects significant financial and operational challenges. The company’s weak financial performance, characterized by substantial losses and cash flow issues, is the most significant factor. Technical analysis indicates a bearish trend, and valuation metrics highlight ongoing financial struggles. These factors collectively result in a low overall stock score.

To see Spark’s full report on IGC stock, click here.

More about IGC Pharma

IGC Pharma, Inc. operates in the pharmaceutical industry and is involved in the development and commercialization of cannabinoid-based therapies. The company focuses on innovative treatments for various health conditions.

Average Trading Volume: 977,680

Technical Sentiment Signal: Sell

Current Market Cap: $33.66M

For detailed information about IGC stock, go to TipRanks’ Stock Analysis page.